Boenning & Scattergood’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Boenning & Scattergood's LLY Position: Q4 2022 in Review
Boenning & Scattergood reduced its Eli Lilly (LLY) stake by 8.7% in Q4 2022, selling an estimated $325K and leaving 9,624 shares worth $2.76M. The position accounts for 0.44% of the portfolio, ranked #55.
Boenning & Scattergood first reported a position in LLY in Q2 2018 and has held it in 19 quarters since. The position peaked at $3.41M in Q3 2022. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- Boenning & Scattergood held 9,624 shares of Eli Lilly worth $2.76M as of Q4 2022.
- Boenning & Scattergood sold 916 Eli Lilly shares in Q4 2022, an estimated $325K.
- Eli Lilly made up 0.44% of Boenning & Scattergood's portfolio in Q4 2022, its #55 holding.
- Boenning & Scattergood first reported a position in Eli Lilly in Q2 2018 and has held it in 19 quarters since.
- Boenning & Scattergood's Eli Lilly position peaked at $3.41M in Q3 2022.
- 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.